Home/Filings/4/0001140361-13-005152
4//SEC Filing

Brooks Jack E 4

Accession 0001140361-13-005152

CIK 0001100592other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 3:08 PM ET

Size

19.9 KB

Accession

0001140361-13-005152

Insider Transaction Report

Form 4
Period: 2013-02-05
Transactions
  • Purchase

    Common Stock

    2013-02-05+769,230865,266 total(indirect: By Pinewood Trading Fund, LP)
  • Other

    16% Convertible Debentures

    2013-02-05+16,00056,000 total(indirect: By Pinewood Trading Fund, LP)
    Exercise: $0.90From: 2011-11-30Exp: 2014-05-30Common Stock (16,000 underlying)
  • Other

    Series B Preferred Stock

    2013-02-05+333,600667,200 total(indirect: By Pinewood Trading Fund, LP)
    Exercise: $0.90Common Stock (333,600 underlying)
  • Other

    Common Stock Warrants

    2013-02-05+32,64080,640 total(indirect: By Pinewood Trading Fund, LP)
    Exercise: $0.90From: 2011-11-30Exp: 2016-11-30Common Stock (32,640 underlying)
  • Purchase

    Common Stock Warrants

    2013-02-05+769,230769,230 total(indirect: By Pinewood Trading Fund, LP)
    Exercise: $0.90From: 2013-02-05Exp: 2016-02-05Common Stock (769,230 underlying)
Holdings
  • Common Stock

    65,000
  • Common Stock

    (indirect: By IRA)
    8,987
Brooks Jack E
10% Owner
Transactions
  • Other

    16% Convertible Debentures

    2013-02-05+16,00056,000 total(indirect: By Pinewood Trading Fund, LP)
    Exercise: $0.90From: 2011-11-30Exp: 2014-05-30Common Stock (16,000 underlying)
  • Other

    Series B Preferred Stock

    2013-02-05+333,600667,200 total(indirect: By Pinewood Trading Fund, LP)
    Exercise: $0.90Common Stock (333,600 underlying)
  • Purchase

    Common Stock

    2013-02-05+769,230865,266 total(indirect: By Pinewood Trading Fund, LP)
  • Other

    Common Stock Warrants

    2013-02-05+32,64080,640 total(indirect: By Pinewood Trading Fund, LP)
    Exercise: $0.90From: 2011-11-30Exp: 2016-11-30Common Stock (32,640 underlying)
  • Purchase

    Common Stock Warrants

    2013-02-05+769,230769,230 total(indirect: By Pinewood Trading Fund, LP)
    Exercise: $0.90From: 2013-02-05Exp: 2016-02-05Common Stock (769,230 underlying)
Holdings
  • Common Stock

    65,000
  • Common Stock

    (indirect: By IRA)
    8,987
Sagewood, LLC
10% Owner
Transactions
  • Purchase

    Common Stock

    2013-02-05+769,230865,266 total(indirect: By Pinewood Trading Fund, LP)
  • Other

    Series B Preferred Stock

    2013-02-05+333,600667,200 total(indirect: By Pinewood Trading Fund, LP)
    Exercise: $0.90Common Stock (333,600 underlying)
  • Other

    Common Stock Warrants

    2013-02-05+32,64080,640 total(indirect: By Pinewood Trading Fund, LP)
    Exercise: $0.90From: 2011-11-30Exp: 2016-11-30Common Stock (32,640 underlying)
  • Other

    16% Convertible Debentures

    2013-02-05+16,00056,000 total(indirect: By Pinewood Trading Fund, LP)
    Exercise: $0.90From: 2011-11-30Exp: 2014-05-30Common Stock (16,000 underlying)
  • Purchase

    Common Stock Warrants

    2013-02-05+769,230769,230 total(indirect: By Pinewood Trading Fund, LP)
    Exercise: $0.90From: 2013-02-05Exp: 2016-02-05Common Stock (769,230 underlying)
Holdings
  • Common Stock

    65,000
  • Common Stock

    (indirect: By IRA)
    8,987
Footnotes (5)
  • [F1]The reported securities are included within Units purchased by the reporting person for an aggregate of $500,000 for the Units. The Units consist of 769,230 shares of Common Stock and 769,230 warrants exercisable for shares of Common Stock.
  • [F2]The reported securities are owned directly by Pinewood Trading Fund, L.P., and indirectly by Sagewood, LLC, as General Partner of Pinewood Trading Fund, L.P., and Jack E. Brooks, as Manager of Sagewood, LLC. Sagewood, LLC and Jack E. Brooks disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.
  • [F3]The reported securities are owned directly and indirectly by Jack E. Brooks.
  • [F4]The shares were acquired as a result of the resetting of the conversion price of the securities previously reported, resulting from the triggering of the anti-dilution adjustments contained in the securities.
  • [F5]Series B Preferred Stock is convertible at any time at the reporting person's election, and has no expiration date.

Documents

1 file

Issuer

ASSURED PHARMACY, INC.

CIK 0001100592

Entity typeother

Related Parties

1
  • filerCIK 0001564823

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 3:08 PM ET
Size
19.9 KB